Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Thaiss

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
BMC Biotechnology|June 28, 2007
Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancerHolger Wulff, Thorsten Krieger, Karen Krüger, et al.
Trials|February 19, 2016
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trialClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
Kidney International|May 25, 2002
Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive ratsUlrich O Wenzel, Gunter Wolf, Ivonne Jacob, et al.
Clinical Transplantation|January 29, 2015
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab inductionAnja M Lehnhardt, Maximiliane Strecker, Thomas Eiermann, et al.
Transplantation Reviews (Orlando, Fla.)|March 12, 2016
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantationJohann Pratschke, Duska Dragun, Ingeborg A Hauser, et al.
Oncology Letters|June 8, 2017
Prostate cancer downregulated SIRP-α modulates apoptosis and proliferation through p38-MAPK/NF-κB/COX-2 signalingChen Yao, Gang Li, Ming Cai, et al.
The Biochemical Journal|July 3, 2009
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammationGunther Zahner, Melanie Schaper, Ulf Panzer, et al.
Kidney International|May 25, 2002
Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptorsGunter Wolf, Ulrich Wenzel, Kevin D Burns, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2017
Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patientsChen Yao, Gang Li, Ming Cai, et al.
American Journal of Physiology. Renal Physiology|September 2, 2016
Lymphocyte-specific deletion of IKK2 or NEMO mediates an increase in intrarenal Th17 cells and accelerates renal damage in an ischemia-reperfusion injury mouse modelLinlin Guo, Hannah Heejung Lee, María de Las Mercedes Noriega, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
BMC Biotechnology|June 28, 2007
Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancerHolger Wulff, Thorsten Krieger, Karen Krüger, et al.
Trials|February 19, 2016
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trialClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
Kidney International|May 25, 2002
Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive ratsUlrich O Wenzel, Gunter Wolf, Ivonne Jacob, et al.
Clinical Transplantation|January 29, 2015
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab inductionAnja M Lehnhardt, Maximiliane Strecker, Thomas Eiermann, et al.
Transplantation Reviews (Orlando, Fla.)|March 12, 2016
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantationJohann Pratschke, Duska Dragun, Ingeborg A Hauser, et al.
Oncology Letters|June 8, 2017
Prostate cancer downregulated SIRP-α modulates apoptosis and proliferation through p38-MAPK/NF-κB/COX-2 signalingChen Yao, Gang Li, Ming Cai, et al.
The Biochemical Journal|July 3, 2009
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammationGunther Zahner, Melanie Schaper, Ulf Panzer, et al.
Kidney International|May 25, 2002
Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptorsGunter Wolf, Ulrich Wenzel, Kevin D Burns, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2017
Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patientsChen Yao, Gang Li, Ming Cai, et al.
American Journal of Physiology. Renal Physiology|September 2, 2016
Lymphocyte-specific deletion of IKK2 or NEMO mediates an increase in intrarenal Th17 cells and accelerates renal damage in an ischemia-reperfusion injury mouse modelLinlin Guo, Hannah Heejung Lee, María de Las Mercedes Noriega, et al.
Pageof 6